To investigate the feasibility of thoracoscopic resection, a pilot study was 
INTRODUCTION
Thoracoscopy has been performed by pulmonologists and thoracic surgeons for more than 80 years. In 1910 the first thoracoscopy was performed by H. C. Jacobaeus, using a modified cystoscope, Initially, thoracoscopy was used for diagnostic purposes in the parietal pleura, diaphragm, pericardium, mediastinum, and most of the lung.2, Then, therapeutic applications, such as talc poudrage, for a spontaneous pneumothorax became possible. But interest in thoracoscopy decreased due to the development of safer operative techniques and the introduction of antituberculous drugs.
In the 1970s, new interest in thoracoscopy emerged due to the development of video imaging technology and new endoscopic instruments. In 1980 Boutin organized the First International Symposium on Thoracoscopy. 4 Many thoracic surgeons have since extended the applications of this procedure to include therapeutic interventions such as mechanical pleurodesis, pleurectomy, bullectomy for pneumothorax, wedge resection, lobectomy and mediastinal mass exploration, and resection for benign and malignant tumors. [2] [3] Even pneumonectomy has been reported to be feasible. 14, 5 For resectable lung tumors, surgery is the first treatment of choice. However, the morbidity for thoracotomy is considerable. 6 Thoracoscopic lobectomy may improve postoperative recovery and reduce the period of hospitalization, which may decrease health care costs.
At present, many surgeons are interested in thoracoscopic lobectomy for lung cancer, but its efficacy has not been clearly demonstrated. 5-9, 4, 5,17-23 (Fig. 1 ).
Pretreatment Investigation
The standard work-up procedure for clinical staging of lung cancer was performed including chest X-rays, computed tomographic scans of the lung and mediastinum, bronchoscopy, and lung function studies.
Surgical Procedure VATS was performed under general anesthesia with a double lumen tube to collapse the ipsilateral lung. The patient was placed in the lateral position to prepare for a possible thoracotomy. In most patients, three trocars (sixth intercostal middle axillary line, fourth intercostal anterior, and posterior axillary lines) were introduced to examine, dissect, and finally resect the tumor. An anterior utility thoracotomy (3 to 10 cm) was performed to aid the thoracoscopic procedure for dissection and removal of the resected specimens when necessary.
RESULTS
Resection of four of six lung tumors suspected of being metastatic was performed thoracoscopically. In the other two patients, a conversion to thoracotomy was necessary (Fig. 1) .
In 27 patients with probable primary lung tumors, resection of the lesion was performed by VATS in 14 (Fig. 2) .
The overall duration of thoracoscopic lobectomy was 3.5 hours. The duration for metastatectomy was 1.8 hours and resection of benign lung tumors was 1.3 hours.
DISCUSSION
Twelve of 40 patients in whom VATS was performed had clinically resectable non-small cell lung cancers. We could perform thoracoscopic lobectomy in only patients (1 of 12 8.3%). Hazelrigg et al. 22 reported in their VATS study group data that in 439 patients (439 of 1820 24.1%)eventual conversion to a thoracotomy occurred. Video-assisted lobectomy was reported in 38 patients and 91 patients underwent lobectomy by thoracotomy after a VATS procedure. 22 The success rate for thoracoscopic lobectomy was therefore 38/(38 + 91 29.5%). But it is unclear in how many patients conversion to wedge resection or pneumonectomy occurred or how many tumors turned out to be inoperable. The success rate for thoracoscopic lobectomy must therefore be less than 29.5%.
Hazelrigg et al. 22 also described their inability to find the lung tumor as a frustrating problem. This occurred in 7.5% of patients, resulting in thoracotomy. In our pilot study, this was the reason for conversion in 4 of 33 (12%) patients. In another 3 patients conversion to thoracotomy was due to technical difficulties (no anatomical fissure, centrally located nodule, or poor lung function requiring whole lung ventilation in patient) ( (Fig. 3) . It is very important, however, to apply oncological principles in thoracoscopic resection of malignancies. Our data clearly show the limitations of VATS for malignant tumors in general. This is in contrast with the more optimistic results of proponents of thoracoscopic resection as previously reported, in which patient selection may influence the success rate of the thoracoscopic approach.
VATS did prevent explorative thoracotomies in 85.7% of the patients, significantly reducing morbidity. Therefore, thoracosopic resection of malignancies is expected to be of only limited usefulness in patients with clinically resectable malignant pulmonary nodules.
These findings together with the fact that thoracoscopic procedures demonstrate a learning curve may limit their use as routine surgical procedures for lobectomy in the suspicion of a malignancy, especially if strict oncological rules are followed.
